share_log

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

AccuStem Science,Inc.宣佈董事長購買股份
GlobeNewswire ·  2022/06/09 13:40

LONDON and PHOENIX, Ariz., June 09, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased 20,000 ACUT shares in the open market. This brings his total holdings to 3,821,226 shares.

亞洲網亞利桑那州倫敦和鳳凰城6月9日電致力於改善癌症患者預後的生命科學公司AccuStem Sciences,Inc.(場外交易市場代碼:ACUT)宣佈,董事會主席加布裏埃爾·切龍先生已通知公司,他最近在公開市場購買了2萬股ACUT股票。至此,他的總持有量達到3821,226股。

About AccuStem

關於AccuStem

AccuStem is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology - to empower patients and their care team with critical answers and tools and drive innovation in healthcare.

AccuStem是一家生命科學公司,致力於優化全球所有癌症患者的預後。該公司從整體上看待其在腫瘤學中的角色-為患者及其護理團隊提供關鍵答案和工具,並推動醫療保健領域的創新。

Media Contact:
Jeff Fensterer
Phone: 415-640-6010
Email: jeff@accustem.com

媒體聯繫人:
傑夫·芬斯特勒
電話:415-640-6010
電子郵件:Jeff@accustem.com

Investor Contact:
Wendy Blosser
Email: investors@accustem.com

投資者聯繫方式:
温迪·布洛瑟
電子郵件:Investors@accustem.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論